Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey.
Switzerland
endocrinologists
fragility fractures
general practitioners
gynecologists
osteoporosis
rheumatologists
risk factors
supplements
survey
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
03 Feb 2022
03 Feb 2022
Historique:
received:
28
10
2021
revised:
24
01
2022
accepted:
26
01
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
Osteoporosis is the most common chronic metabolic bone disease, known to be underdiagnosed and undertreated in parts of the Swiss population. Due to expected rise in new fragility fractures, adequate awareness of associated risk factors and diagnostic and therapeutic options will be essential for the management of osteoporosis. We therefore explored these aspects in a nationwide survey of Swiss specialists and their patients. A total of 262 physician questionnaires and 9065 patient questionnaires were analyzed, mainly from general practitioners (64.9%), followed by rheumatologists (16.8%), gynecologists (12.2%), and endocrinologists (6.1%). Around 20% of patients were under medication and/or had a medical condition increasing the risk of osteoporosis. Further risk factors, such as low consumption of calcium-rich foods, smoking, elevated alcohol intake, and insufficient physical activity, were present across regions and medical fields. 53.9% of patients did not take calcium/vitamin D supplements; 3.5% reported having fragility fractures, and 7.3% received treatment for osteoporosis. Only 38.5% of surveyed patients knew of the chronic nature of osteoporosis, indicating rather low awareness in this population. Despite generally perceived relevance of osteoporosis for daily practice, aspects of its prevention and management varied across regions and medical fields. Raising awareness among patients and physicians will be vital for addressing osteoporosis on a national scale.
Identifiants
pubmed: 35206909
pii: healthcare10020295
doi: 10.3390/healthcare10020295
pmc: PMC8871550
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Osteoporos Int. 2014 Oct;25(10):2359-81
pubmed: 25182228
Bone. 2003 May;32(5):468-73
pubmed: 12753862
Aging Clin Exp Res. 2016 Aug;28(4):797-803
pubmed: 27299902
Climacteric. 2015;18 Suppl 2:22-31
pubmed: 26473773
Nutr Bull. 2014 Dec;39(4):322-350
pubmed: 25635171
Swiss Med Wkly. 2011 Aug 31;141:w13260
pubmed: 21882122
Osteoporos Int. 2010 Mar;21(3):381-9
pubmed: 19517155
BMC Musculoskelet Disord. 2018 May 14;19(1):144
pubmed: 29759066
BMC Public Health. 2018 Apr 2;18(1):423
pubmed: 29606111
PLoS One. 2019 Jul 16;14(7):e0219681
pubmed: 31310619
Ann R Coll Surg Engl. 2013 Jan;95(1):5-7
pubmed: 23317709
Osteoporos Int. 2021 Feb;32(2):251-259
pubmed: 32829471
Swiss Med Wkly. 2007 May 19;137(19-20):292-9
pubmed: 17594542
Arch Osteoporos. 2019 Apr 30;14(1):50
pubmed: 31041620
J Clin Med Res. 2017 May;9(5):382-387
pubmed: 28392857
Arch Osteoporos. 2017 Dec;12(1):43
pubmed: 28425085
Arch Osteoporos. 2014;9:187
pubmed: 24970672
Cochrane Database Syst Rev. 2014 Apr 14;(4):CD000227
pubmed: 24729336
Front Pharmacol. 2017 May 11;8:258
pubmed: 28553228
Eur J Rheumatol. 2017 Mar;4(1):46-56
pubmed: 28293453
Swiss Med Wkly. 2008 Nov 15;138(45-46):674-83
pubmed: 18855150
Nutrients. 2017 Oct 25;9(11):
pubmed: 29068399
JAMA. 2001 Feb 14;285(6):785-95
pubmed: 11176917
Eur J Clin Nutr. 2009 Feb;63(2):273-81
pubmed: 17940542
J Am Osteopath Assoc. 2019 Jun 1;119(6):357-363
pubmed: 31135863
Swiss Med Wkly. 2011 May 27;141:w13196
pubmed: 21623475
Osteoporos Int. 2005 Mar;16 Suppl 2:S8-S17
pubmed: 15378232
Swiss Med Wkly. 2014 Feb 26;144:w13931
pubmed: 24573548
Swiss Med Wkly. 2020 Sep 29;150:w20352
pubmed: 33038260
Osteoporos Int. 2010 Jun;21 Suppl 2:S407-13
pubmed: 20464374